Pharmacy

World Health Organization Chief Scientist Soumya Swaminathan has praised India for becoming the pharmacy of the world in the last 75 years. She enumerated India's four major successes that are eradication of polio, a few other vaccine-preventable diseases, the reduction of maternal and child mortality, and universal health coverage. However, she said, "The Covid-19 pandemic has also increased the poverty rate...so...we'll need to...take… read-more

BDR Pharma announced that its prostate cancer drug, Enzalutamide, will be available in 80mg in India to reduce the pill burden on patients. The tablets are used to treat men with metastatic Castration-Resistant Prostate Cancer (mCRPC) and are priced at Rs 24,480 per pack, consisting of four strips. Earlier, in 2017, BDR Pharma had received authorization from the Drug Controller General of India (DCGI) for its 40mg version of Enzalutamide.

US Food and Drug Administration (USFDA) has given preliminary approval for the Treprostinil injection, which aims to treat pulmonary arterial hypertension. The drug is produced by the subsidiary of Alembic Pharmaceuticals and is expected to be equivalent to Remodulin Injection. Patients with pulmonary arterial hypertension experience high blood pressure in arteries that go from the heart to the lungs.

The Mylan Laboratories Ltd's Unit 7 is deviating from the Current Good Manufacturing Practices(CGMP), warned the US Food and Drug Administration (FDA). The FDA, in its letter to Mylan, said that the company had not followed adequate cleaning measures and testing of raw materials for impurities; this could contaminate the materials that are used to produce medicines. The plant is located in the Sangareddy district of Telangana.